Jennifer Pietenpol Archive — Page 1 of 10

Complex scatterplot titled “Transcriptional Breast Cancer Atlas,” showing colored clusters of points labeled Neuroendocrine, Mucinous, HER2E ER, HER2E KIS, LumB, LumA, Fibroblast ER, Immune-dominant, Basal M, Basal IM, Basal BL1, Stem-like, LAR, and Normal, with a compass rose in the lower-left corner.
November 3, 2026

Breast cancer atlas helps chart course for precision oncology

The new map integrates data from more than 7,600 tumors across 22 independent studies and reveals previously hidden forms of breast cancer that differ in prognosis, biology and treatment sensitivity.

By Leigh MacMillan
Alexander Bick, MD, PhD
August 12, 2026

Alexander Bick to lead cutting-edge resource for genomic discovery at Vanderbilt Health

Vanderbilt Technologies for Advanced Genomics is a one-stop genomics research resource that offers sample biobanking, genome sequencing, single-cell and spatial multiomic profiling, and other specialized services.

By Bill Snyder
Exterior of the brick Vanderbilt-Ingram Cancer Center building, with the name displayed above its glass entrance and “Frances Williams Preston Building” marked along the lower facade.
June 23, 2026

Vanderbilt Health lands three of 35 Susan G. Komen research grants

Komen is the largest nonprofit funder of breast cancer research outside of the U.S. government, having invested more than $1.1 billion in research since its founding.

By Yolanda James
June 10, 2026

Improving Health Outcomes

By diana
Aerial view of Vanderbilt Health’s main campus, showing a dense complex of modern and brick medical buildings surrounded by trees, roads, and the wider city landscape.
February 24, 2026

Vanderbilt University School of Medicine ranks seventh in NIH support of disease-fighting research

Six clinical departments and two basic science departments at VUSM ranked in the top 10 among medical school departments nationwide in fiscal year 2025.  

By Bill Snyder
(Photo credit: iStock photo)
June 26, 2025

Three VUMC researchers receive Komen leadership grants

The grants support 25 cutting-edge projects at 17 institutions — marking a powerful commitment to improving outcomes for people living with breast cancer today and in the future.

By Tom Wilemon